drugset / Trial / NCT01724554

Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion

NCT01724554

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to look at how effective, safe, and well tolerated Intravitreal Aflibercept Injection is in subjects with Central Retinal Vein Occlusion (CRVO) or Proliferative Diabetic Retinopathy (PDR).

Timeline

Start
2012-11
Primary completion
2014-10
Completion
2014-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Aflibercept Protein / enzyme biologic Intravitreal